Eun-Som Kim

Title: Eun-Som Kim: Innovator in Vaccine Development

Introduction

Eun-Som Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of vaccine development through his innovative research and patents. His work focuses on enhancing the efficiency of vaccine production using novel cell lines.

Latest Patents

Eun-Som Kim holds a patent for a Vero cell line that can be suspension-cultured in serum-free medium. The patent, titled "Vero cell line that can be suspension-cultured in serum-free medium, preparation method therefor, and method for preparing viruses for vaccines by using novel cell line," relates to sVERO 7C2. This Vero cell line is derived from the African Green Monkey Kidney Cell Line distributed by the WHO and is capable of suspension culture without serum components. The patent also includes a culture method for growing the Vero cells and a method for producing a vaccine virus using these cells. He has 1 patent to his name.

Career Highlights

Eun-Som Kim is currently employed at SK Bioscience Co., Ltd., where he continues to advance his research in vaccine technology. His work has been instrumental in developing methods that improve the production of vaccine viruses, which is crucial for public health.

Collaborations

Eun-Som Kim collaborates with Jun-seok Kwak, contributing to the innovative research environment at SK Bioscience Co., Ltd. Their partnership enhances the potential for breakthroughs in vaccine development.

Conclusion

Eun-Som Kim's contributions to vaccine development through his innovative patent and work at SK Bioscience Co., Ltd. highlight his importance in the field. His research is paving the way for more efficient vaccine production methods, which can have a significant impact on global health.